Eylea is contraindicated in patients with infections or active inflammations of or near the eye, while Zaltrap has no contraindications.
Aflibercept
Vatalanib
Nintedanib
Ranibizumab
Angiozyme
Avelumab
Gilteritinib
Abrocitinib